Juvenile onset central nervous system folate deficiency and rheumatoid arthritis

Journal of Child Neurology

Volumn 23, Issue 1, 2008, Pages 106-107

  Koenig, Mary Kay ^a   Perez, Maria ^b   Rothenberg, Sheldon ^c   Butler, Ian J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Autoantibody; Folate; Rheumatoid

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; AUTOANTIBODY; ETANERCEPT; FOLATE RECEPTOR; FOLIC ACID; METHOTREXATE; NAPROXEN; STEROID;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CERVICAL MYELOPATHY; CHOROID PLEXUS; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; IMAGE ANALYSIS; JUVENILE RHEUMATOID ARTHRITIS; MOTOR DYSFUNCTION; NERVE STIMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARANOIA; PARESTHESIA; PRIORITY JOURNAL; SUICIDAL IDEATION; URINE INCONTINENCE;

ADOLESCENT; AFFECTIVE SYMPTOMS; AGE OF ONSET; ARTHRITIS, JUVENILE RHEUMATOID; AUTOANTIBODIES; BRAIN; BRAIN DISEASES, METABOLIC; CARRIER PROTEINS; CHOROID PLEXUS; COGNITION DISORDERS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; MAGNETIC RESONANCE IMAGING; MOTOR SKILLS DISORDERS; RECEPTORS, CELL SURFACE; SPINAL CORD; TETRAHYDROFOLATES;

EID: 37449011196     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807307986     Document Type: Article

References (9)

1. Kolen ER, Schmidt MH Rheumatoid arthritis of the cervical spine. Semin Neurol. 2002;22:179-186.
2. Ramaekers VT, Rothenberg SP, Sequeria JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352:1985-1991.
3. Paimela L., Laasonen L., Kankaanpaa E., et al. Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol. 1997;24:1280-1284.
4. Endresen GKM, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. Scand J Rheumatol. 2001;30:129-134.
5. Pearce GJ, Chikanza IC Targeting tumour necrosis factor in the treatment of rheumatoid arthritis. BioDrugs. 2001;15:139-149.
6. Mohan N., Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor therapy for inflammatory arthritides. Arthritis Rheum. 2001;44:2862-2869.
7. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;240:253-259.
8. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004;46:843-851.
9. Van Boekel MAM, Vossenaar ER, van den Hoogen FHJ. Autoantibody systems in rheumatoid arthritis: Specificity, sensitivity and diagnostic value. Arthritis Res. 2002;4:87-93.